Waystar Considers Sale Amid Declining Market Valuation

Waystar, a prominent player in the healthcare software industry, is reportedly considering various strategic options, including a potential sale. This move comes as the company's market valuation has decreased significantly, according to sources familiar with the situation. The company, which went public in New York two years ago, has seen a 24% drop in its share price this year amid a broader decline in the software sector.

Investment Banking Guidance

Based in Lehi, Utah, and Louisville, Kentucky, Waystar has enlisted the services of investment bank Evercore to advise on its strategic review process. The review is still in its early stages, and there is no certainty that a sale will occur, as the plans could change. Both Waystar and Evercore have declined to comment on the matter.

Market Challenges and Strategic Positioning

Waystar has sought to differentiate itself as a healthcare software company focused on automating administrative tasks, aiming for the higher valuations typically associated with technology firms. Initially, investors responded positively, driving the stock from $20 to a high of $45 in 2025. However, concerns over potential disruptions from advancements in artificial intelligence have since pressured the stock.

The company's market value currently stands at approximately $4.8 billion. An auction process could help determine whether investor interest in software companies is resurging.

Corporate History and Shareholder Structure

Waystar was formed in 2017 through the merger of healthcare revenue management companies Zirmed and Navicure. Major stakeholders include EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital, who took the company public in 2024. EQT remains the largest shareholder with a 13% stake, while CPPIB holds 10%, and BlackRock Institutional Trust Company owns 8%, according to data from LSEG.

As the company navigates these strategic decisions, the outcome could significantly impact its trajectory and the landscape of healthcare software management.